Inflammation Following Cataract Surgery

• FDA approval · 2025-02-18
  FDA Approved: BROMFENAC OPHTHALMIC SOLUTION — Supplemental Application (Bausch & Lomb Americas Inc.)

  FDA approved a supplemental NDA for Bromfenac Ophthalmic Solution (bromfenac sodium) from Bausch & Lomb Americas Inc. to support use for pos…

• FDA approval · 2020-11-04
  FDA Approved: NEVANAC — Supplemental Application (Harrow Eye, LLC)

  The FDA approved a supplemental application for NEVANAC (nepafenac) submitted by Harrow Eye, LLC.

• FDA approval · 2013-12-09
  FDA Approved: ILEVRO — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for ILEVRO (nepafenac) from Novartis Pharmaceuticals Corporation. The approval updates labeling to r…